Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection Clinical research trials and Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection. Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection clinical trial. Participants frequently get the best healthcare available for their Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.

Home > "V" Clinical Trials Conditions > Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection

Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection



Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection

For Condition: Healthy,Communicable Diseases
Status: Terminated
Sponsor(s): National Institute of Allergy and Infectious Diseases (NIAID) ,
Synopsis: The purpose of this study is to follow responses to treatment with vaccinia immune globulin (VIG) for safety and clinical benefit [during HIV vaccine research]. VIG is purified from human blood and used to treat serious infections of the vaccinia (smallpox vaccine) virus or similar viruses. It is the only treatment available for those viruses. The only available supply of VIG has developed a discoloration over time and therefore is considered an investigational new drug by the FDA. This study will allow it to be used for intramuscular injection in a controlled setting for people who may need it [during HIV vaccine research].
Details: VIG (Human) is a component of plasma from persons vaccinated with vaccinia vaccine. It is the only product available for the treatment of vaccinia and other orthopox infections. The only lot currently available was released as a licensed product in 1995 but is being treated as an investigational new drug because of slight discoloration in the solution. This study makes existing stocks of VIG available as a short-term solution for the lack of a licensed immune globulin to treat vaccinal infections. Before receiving injections and 3 and 6 months after injections, patients are tested for HIV, hepatitis B, and hepatitis C with pre- and post-test counseling. Referrals for appropriate medical care are provided. Participants have multiple injections (depending on body weight) of VIG at 1 or 2 clinic visits. Following administration of VIG, participants are observed for 1/2 hour at the clinic. Participants return to the clinic for as many as 10 visits to monitor for any adverse reactions and signs and symptoms of vaccinia infections. On Days 7, 84, and 168 participants return to the clinic for evaluations and have blood drawn to check for the response to the VIG injections.
Eligibility:
Study Type:  Interventional, Treatment, Safety Study
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Participants may be eligible for this study if they: - Sign a consent form including consent for pre/post HIV counseling. If under 18 years or unable to sign a consent form, the next of kin or a legal guardian must sign. - Experience complications from prior administration of vaccinia virus vaccinations or accidental exposure to vaccinia or similar viruses. - Have a pregnancy test. Exclusion Criteria Participants will not be eligible for this study if they: - Have eye complications. Note: - Caution should be noted if participants are allergic to thimerosal (a preservative in the study drug). Precautions can be taken if participants experience a reaction during VIG administration. - Women who are pregnant will be counseled about risks.
Total Enrollment: 

Location and Contact Information:

Drienna Holman
Seattle,  Washington,  98109
United States
 


Additional Information:
Study ID Numbers:  AVEG 801; 
Study Start Date: 
Record last reviewed: June 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00006630

Other Healthy Studies:
1. Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection

2. Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy

Related Studies:

Other Healthy Clinical Trials
Other Washington Clinical Trials
Other Seattle Clinical Trials

Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection
Modify your Search

  Other Healthy Clinical Trials
  Other Washington Clinical Trials
  Other Seattle Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103